Paper41585376
Enhanced AAV production via rational design of a novel pHelper vector integrated with HSV-1 helper genes.
Ren H and 5 others. Synth Syst Biotechnol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Enhanced AAV production via rational design of a novel pHelper vector integrated with HSV-1 helper genes. Papers, record 41585376. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585376
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced AAV production via rational design of a novel pHelper vector integrated with HSV-1 helper genes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26437810 | Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. | Mol Ther | 2016 | https://conductscience.org/library/papers/26437810 | PubMed |
| 2 | 32042148 | Engineering adeno-associated virus vectors for gene therapy. | Nat Rev Genet | 2020 | https://conductscience.org/library/papers/32042148 | PubMed |
| 3 | 30591923 | Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells. | Mol Ther Methods Clin Dev | 2019 | https://conductscience.org/library/papers/30591923 | PubMed |
| 4 | 36776482 | Understanding capsid assembly and genome packaging for adeno-associated viruses. | Future Virol | 2017 | https://conductscience.org/library/papers/36776482 | PubMed |
| 5 | 33495615 | The clinical landscape for AAV gene therapies. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33495615 | PubMed |
| 6 | 28669112 | Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. | BioDrugs | 2017 | https://conductscience.org/library/papers/28669112 | PubMed |
| 7 | 33071047 | Journey to the Center of the Cell: Tracing the Path of AAV Transduction. | Trends Mol Med | 2021 | https://conductscience.org/library/papers/33071047 | PubMed |
| 8 | 16699004 | Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication. | J Virol | 2006 | https://conductscience.org/library/papers/16699004 | PubMed |
| 9 | 38336188 | Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing. | Biotechnol Adv | 2024 | https://conductscience.org/library/papers/38336188 | PubMed |
| 10 | 34711462 | Adeno-associated virus (AAV) cell entry: structural insights. | Trends Microbiol | 2022 | https://conductscience.org/library/papers/34711462 | PubMed |
| 11 | 15313607 | Catalysis of strand exchange by the HSV-1 UL12 and ICP8 proteins: potent ICP8 recombinase activity is revealed upon resection of dsDNA substrate by nuclease. | J Mol Biol | 2004 | https://conductscience.org/library/papers/15313607 | PubMed |
| 12 | 30710128 | Adeno-associated virus vector as a platform for gene therapy delivery. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30710128 | PubMed |
| 13 | 37126355 | Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing. | Biotechnol Bioeng | 2023 | https://conductscience.org/library/papers/37126355 | PubMed |
| 14 | 9813665 | Adeno-associated virus vectors can be efficiently produced without helper virus. | Gene Ther | 1998 | https://conductscience.org/library/papers/9813665 | PubMed |
| 15 | 36627108 | Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies. | ACS Synth Biol | 2023 | https://conductscience.org/library/papers/36627108 | PubMed |
| 16 | 10933916 | Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. | Mol Ther | 2000 | https://conductscience.org/library/papers/10933916 | PubMed |
| 17 | 38323812 | Human Bocavirus 1 NP1 acts as an ssDNA-binding protein to help AAV2 DNA replication and cooperates with RPA to regulate AAV2 capsid expression. | J Virol | 2024 | https://conductscience.org/library/papers/38323812 | PubMed |
| 18 | 37127491 | Challenges in scaling up AAV-based gene therapy manufacturing. | Trends Biotechnol | 2023 | https://conductscience.org/library/papers/37127491 | PubMed |
| 19 | 38692443 | Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms. | Biotechnol Adv | 2024 | https://conductscience.org/library/papers/38692443 | PubMed |
| 20 | 36103998 | Adeno-Associated Virus Gene Therapy for Hemophilia. | Annu Rev Med | 2023 | https://conductscience.org/library/papers/36103998 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41585376
GET https://conductscience.org/api/papers/v1/41585376/references?page=2